Lonza Group AG
CHCHFLonza Group AG (US:LZAGF) — Diagnostics & Research. Number of exchanges where the company shares trade: 3. On this page — price and chart, dividends, top holders and share count history.
About the company
- Website
- lonza.com
- Sector
- Healthcare · Diagnostics & Research
- Headquarters
- Basel, Switzerland
- Management
- Wolfgang Wienand
- Employees
- 20 141
- Shares outstanding
- 69.84 M
- Free float
- 69.74 M
- Market cap
- 39.35 B CHF
- Insiders
- 0.09%
- Institutions
- 58.65%
- P/EP/E (Price / Earnings) — how many years of the company's profit you pay for a share. Calculated: current price ÷ net earnings per share over the last 12 months. Lower means cheaper relative to profit. Not calculated when the company has a loss (—).
- 43.8
- EPSEPS (Earnings Per Share) — the company's net profit over the last 12 months divided by the number of its shares, in the currency of this listing. A negative value (red) means a loss. P/E is the share price divided by EPS.
- 19.01 USD
- |P/B (price to book) — share price ÷ shareholders' equity per share from the latest balance sheet. Graham — as Benjamin Graham counted it: equity without goodwill, other intangible assets and preferred stock, that is tangible book value. He considered up to 1.5 acceptable for a defensive investor (green), or a product P/E × P/B up to 22.5. With negative tangible equity, Graham's P/B is not calculated.
- 5.427.53
- Graham numberGraham number — the highest price Benjamin Graham considered reasonable for a defensive investor: √(22.5 × EPS × tangible book value per share), where 22.5 = P/E 15 × P/B 1.5. A price below it (green) passes both of his limits at once. Not calculated with a loss or negative tangible equity.
- 217 USD price 283% above
- Payout ratioPayout ratio — what share of net income the company pays out as dividends. Calculated: dividends paid over the last 12 months ÷ net income for the same 12 months × 100%. Up to 60% — safe margin, 60–90% — borderline, over 90% — dividend at risk of a cut. «Loss» — the company pays without a profit.
- loss
- FCFFCF (Free Cash Flow) — money left to the company after operating costs and investment in equipment; dividends are safest when paid from it. Calculated: operating cash flow − capital expenditure, over the last 12 months, in the reporting currency.
- 155 M CHF
- Payout / FCFShare of free cash flow (FCF) the company paid out as dividends: dividends paid over 12 months ÷ FCF × 100%. Up to 60% — room to spare, 60–90% — borderline, over 90% — risky. Over 100% — paid more than it earned in free cash: the gap was covered by cash reserves, new borrowing or new shares, which cannot last long.
- 242%
- DebtDebt — all loans and bonds of the company per the latest report (short- and long-term), in the reporting currency. Below — how many years the company would need to repay net debt (debt minus cash) from its free cash flow: net debt ÷ FCF. Up to 3 years — good, 3–6 — moderate, over 6 — high. «Net cash» — net debt is negative.
- 4.17 B CHF24 y of FCF
- Dividend streakDividend streak — how many years in a row the company has paid dividends without a break longer than 18 months. Counted from the earliest payment of the unbroken chain until today. «+» — data history starts in 1970, so the real streak may be longer. The longer the streak, the likelier the company keeps paying through crises.
- 13 y
- Earnings, FCF and dividends paid — for the 12 months to 30.06.2026 (the company's latest report).
- NAVNAV — net asset value by the balance sheet: the company's assets minus its liabilities, the share of the company's shareholders (without other owners' stakes in its subsidiaries). Shown per share, with P/NAV — how many times the share price exceeds NAV per share (below 1 — the share costs less than its net assets on the balance sheet). Click to see what NAV is made of and its history.
Description
Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Exchanges and tickers
| Exchange | Ticker | Currency | Price | Type |
|---|---|---|---|---|
| common stock | ||||
| SW SIX Swiss Exchange | LONN primary | CHF | 629.8 -0.94% | common stock |
| LSE London Stock Exchange | 0QNO IOB | CHF | 566 +0.00% | common stock |
| US USA Stocks | LZAGF OTC | USD | 832.45 +4.34% | common stock |
| depositary receipt | ||||
| SG Singapore Exchange | O6Z | SGD | 79.97 +0.00% | depositary receipt |
| US USA Stocks | LZAGY | USD | 81.9 +0.56% | depositary receipt |
Dividends
Lonza Group AG (LONN) pays dividends irregularly. Per year (12 months up to and including the latest announced payment): 5 CHF per share (payments: 1). That is about 0.79% of the current share price. Based on payment history, the next ex-dividend date is expected around 12.05.2027. Uninterrupted dividend history: 13 years.
Ordinary shares
| Ex-date | Payment | Amount | % | Type | Ticker |
|---|---|---|---|---|---|
| 2026-05-12 | 2026-05-15 | 5.0000 CHF | 1.0/1.0 % | annual | SW:LONN |
| 2025-05-13 | 2025-05-15 | 4.0000 CHF | 0.7/0.7 % | annual | SW:LONN |
| 2024-05-13 | 2024-05-15 | 4.0000 CHF | 0.8/0.8 % | annual | SW:LONN |
| 2023-05-09 | — | 3.5000 CHF | 0.6/0.6 % | annual | SW:LONN |
| 2022-05-09 | — | 3.0000 CHF | 0.5/0.5 % | annual | SW:LONN |
Depositary receipts
| Ex-date | Payment | Amount | % | Type | Ticker |
|---|---|---|---|---|---|
| 2026-05-13 | 2026-06-04 | 0.570703 USD | 0.7/1.2 % | regular | US:LZAGY |
| 2025-05-14 | 2025-05-30 | 0.429902 USD | 0.5/0.8 % | regular | US:LZAGY |
| 2024-05-15 | 2024-05-29 | 0.220264 USD | 0.3/≈0.3 % | regular | US:LZAGY |
| 2026-05-12 | 2026-05-15 | 2.5 CHF | — | regular | SG:O6Z |
Top holders
| Holder | Stake | Shares | Report date |
|---|---|---|---|
| VANGUARD WORLD FUND-Vang… | 1.53% | 1.08 M | 2026-05-31 |
| VANGUARD STAR FUNDS-Vang… | 1.46% | 1.03 M | 2026-07-31 |
| VANGUARD TAX-MANAGED FUN… | 0.97% | 683 586 | 2026-06-30 |
| iShares Trust-iShares Co… | 0.75% | 523 911 | 2026-08-31 |
| College Retirement Equit… | 0.46% | 321 600 | 2026-06-30 |
| Fidelity Concord Street… | 0.39% | 275 226 | 2026-08-31 |
| iShares Trust-iShares MS… | 0.36% | 250 275 | 2026-08-31 |
| HARTFORD MUTUAL Fd.S II… | 0.31% | 217 641 | 2026-07-31 |
| AIM Intl Mutual Fd.s -In… | 0.26% | 181 029 | 2026-07-31 |
| College Retirement Equit… | 0.25% | 172 301 | 2026-06-30 |
| Pacer Advisors, Inc. | 0% | 543 | 2026-06-30 |
| Main Street Group, Ltd | 0% | 124 | 2026-06-30 |
| Gamma Investing LLC | 0% | 92 | 2026-06-30 |
Sign in with Google